According to the classic Massachusetts Aging Male Study [Feldman et al. 1994], the prevalence of ED is approximately 50% at 50 years, rising to 70% after 70 years. In a study carried out in Japan, Malaysia, Italy and Brazil, Nicolosi and colleagues reported a prevalence of complete or moderate ED of 9% in males aged 40-44 years, achieving 54% in those between 65 and 70 years of age [Nicolosi et al. 2003].The prevalence of LUTS/BPH also rises with age. According to Chute and colleagues, it amounts to 24% among men aged 40-49 years and to 36% in males aged 60-69 years [Chute et al. 1993].This correlation between two clinical entities could be just a statistical fact: two diseases affecting the same age group.However, there are several indications that make one consider that there might be a pathophysiologic interaction between ED and LUTS/BPH. This review is designed to highlight the evidence for a common pathophysiology, and some of which is still hypothetical.
MethodsA search was performed in Medline using the keywords of the Medical Subject Headings (MESH) 'erectile dysfunction' and 'lower tract Pathogenic mechanisms linking benign prostatic hyperplasia, lower urinary tract symptoms and erectile dysfunction Sidney Glina and Felipe Placco Araujo Glina Abstract Introduction: Erectile dysfunction (ED) and lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH) are clinical entities very prevalent in men aged over 50 years. There is evidence that both may have a common pathophysiology. Objective: The objective of this study was to conduct a literature review aiming to show theories and hypotheses that justify a single pathophysiology for ED and LUTS/BPH. Methods: A search in Medline using the keywords of the Medical Subject Headings (MESH) 'erectile dysfunction' and 'lower urinary tract symptoms' in all fields of the database up to 15 December 2012. This search found 198 relevant articles that were analyzed. Results: The data and articles were divided according to the type of evidence found. There are strong epidemiological data showing that LUTS/BPH is a risk factor for developing ED. Several experimental models demonstrated partial obstruction of the bladder in animals causes voiding disorders as well as a negative impact on erectile function of the operated animals. The increased adrenergic tonus in animals leads to prostate growth and urodynamic conditions similar to those found in men with LUTS and ED. Arteriosclerosis may lead to loss of vesical complacency, urinary tract obstruction and fibrosis of the cavernous bodies. The use of phosphodiesterase type 5 inhibitors (PDE-5i) and/or alpha-adrenergic blockers to treat ED and LUTS/BPH reinforces the hypothesis that, at least in some patients, both clinical pictures may have the same pathophysiology. This search resulted in 198 relevant articles that were analyzed. This is not a systematic review and included only data that were significant to the hypotheses and theories showing the pathogenic mechanisms relating LUTS/BPH to ED. In the c...